Applying a multiple screening program aided by a guideline-driven computerized decision support system - A pilot experience in Yun-Lin, Taiwan

Journal of the Formosan Medical Association

Volumn 106, Issue 1, 2007, Pages 58-68

  Lin, Jou Wei ^a   Chu, Pei Lun ^a   Liou, Jyh Ming ^a   Hwang, Juey Jen ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Cost benefit analysis; Decision support techniques; Evidence based medicine; Mass screening; Preventive health services

Indexed keywords

ACETYLSALICYLIC ACID;

ADULT; AGED; ANAMNESIS; ANTHROPOMETRY; ARTICLE; BLOOD GLUCOSE MONITORING; BONE DENSITOMETRY; BREAST CANCER; CLINICAL PROTOCOL; CLINICAL TRIAL; COLORECTAL CANCER; COMPUTER ASSISTED DIAGNOSIS; COMPUTER PROGRAM; COST EFFECTIVENESS ANALYSIS; DECISION SUPPORT SYSTEM; DEMOGRAPHY; DEPRESSION; DIET RESTRICTION; DYSLIPIDEMIA; EVIDENCE BASED MEDICINE; FEMALE; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE QUALITY; HEALTH PROGRAM; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MAMMOGRAPHY; MEDICAL INFORMATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OSTEOPOROSIS; PAPANICOLAOU TEST; PATIENT EDUCATION; PATIENT REFERRAL; PREVENTIVE HEALTH SERVICE; PRIMARY HEALTH CARE; QUESTIONNAIRE; SCORING SYSTEM; SCREENING TEST; SMOKING CESSATION; TAIWAN; TOBACCO DEPENDENCE; UTERINE CERVIX CANCER;

EID: 33846884425     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0929-6646(09)60217-5     Document Type: Article

References (54)

1. Hensrud DD. Clinical preventive medicine in primary care: background and practice: 1. Rationale and current preventive practices. Mayo Clin Proc 2000;75:165-72.
2. Hensrud DD. Clinical preventive medicine in primary care: background and practice: 2. Delivering primary preventive services. Mayo Clin Proc 2000;75:255-64.
3. US Preventive Services Task Force (USPSTF). Available at: http://www.ahrq.gov/clinic/uspstfix.htm
4. US Preventive Services Task Force Ratings. Strength of Recommendations and Quality of Evidence. Guide to Clinical Preventive Services, Third Edition: Periodic Updates, 2000-2003. Rockville, MD: Agency for Healthcare Research and Quality. Available at: http://www.ahrq.gov/ clinic/3rduspstf/ratings.htm
5. Hunt DL, Haynes RB, Hanna SE, et al. Effect of computer-based clinical decision support systems on physician performance and patient outcomes: a systematic review. J Am Med 1998;280:1339-46.
6. Tierney WM, Hui SL, McDonald CJ. Delayed feedback of physician performance versus immediate reminders to perform preventive care. Effects on physician compliance. Med Care 1986;24:659-66.
7. Becker DM, Gomez EB, Kaiser DL, et al. Improving preventive care at a medical clinic: how can the patient help? Am J Prev Med 1989;5:353-9.
8. McPhee SJ, Bird JA, Jenkins CN, et al. Promoting cancer screening. A randomized controlled trial of three interventions. Arch Intern Med 1989;149:1866-72.
9. Fordham D, McPhee SJ, Bird JA, et al. The Cancer Prevention Reminder System. MD Comput 1990;7:289-95.
10. Kawamoto K, Houlihan CA, Balas EA, et al. Improving clinical practice using clinical decision support systems: a systematic review of trials to identify features critical to success. BMJ 2005;330:765.
11. National Taiwan University Hospital Yun-Lin Branch. Online introduction. Available at: http://www.ylh.ntuh.mc.ntu.edu.tw/ylh/002/4.pdf [In Chinese]
12. US Preventive Services Task Force. Aspirin for the Primary Prevention o f Cardiovascular Events: Recommendations and Rationale. Rockville, MD: Agency for Healthcare Research and Quality, January 2002. Available at: http://www.ahrq.gov/clinic/3rduspstf/aspirin/asprr.htm
13. Harris R, Donahue K, Rathore S, et al. Screening adults for type 2 diabetes: a review of the evidence for the US Preventive Services Task Force. Ann Intern Med 2003; 138:215-90.
14. Harris R, Lux L, Bunton A, et al. Screening for Type 2 Diabetes Mellitus. Systematic Evidence Review No. 19. (Prepared by Research Triangle Institute-University of North Carolina Evidence-based Practice Center under Contract No. 290-97-0017). Rockville, MD: Agency for Healthcare Research and Quality, May 2002. Available at: www.ahrq.gov/ clinic/serfiles.htm
15. Pignone MP, Phillips CJ, Atkins D, et al. Screening and treating adults for lipid disorders. Am J Prev Med 2001; 20:77-89.
16. Sheridan S, Pignone M, Donahue K. Screening for high blood pressure: a review of the evidence for the US Preventive Services Task Force. Am J Prev Med 2003; 25:151-8.
17. Peeters A, Barendregt JJ, Willekens F, et al. Obesity in adulthood and its consequences for life expectancy: a life-table analysis. Ann Intern Med 2003;138:24-32.
18. US Preventive Services Task Force. Counseling to Prevent Tobacco Use and Tobacco-Related Diseases: Recommendation Statement. Rockville, MD: Agency for Healthcare Research and Quality, November 2003. Available at: http://www.ahrq.gov/clinic/3rduspstf/tobacccoun/tobcounrs.htm
19. US Preventive Services Task Force. Screening for Depression: Recommendations and Rationale. Rockville, MD: Agency for Healthcare Research and Quality, May 2002. Available at: http://www.ahrq.gov/clinic/ 3rduspstf/depressrr.htm
20. US Preventive Services Task Force. Screening for colorectal Cancer: Recommendations and Rationale. Rockville, MD: Agency for Healthcare Research and Quality, July 2002. Available at: http://www.ahrq.gov/ clinic/3rduspstf/colorectal/colorr.htm
21. Humphrey LL, Helfand M, Chan BKS. Breast cancer screening: a summary of the evidence for the US Preventive Services Task Force. Ann Intern Med 2002;137: 347-60.
22. Hartman KE, Hall SA, Nanda K, et al. Screening for Cervical Cancer. Systematic Evidence Review No. 25. Rockville, MD: Agency for Healthcare Research and Quality, January 2002. Available at: http://www.ahrq.gov/ clinic/serfiles.htm
23. Nelson HD, Helfand M, Woolf SH, et al. Screening for postmenopausal osteoporosis: a review of the evidence for the US Preventive Services Task Force. Ann Intern Med 2002;137:529-41.
24. Nelson HD, Helfand M. Screening for Postmenopausal Osteoporosis. Systematic Evidence Review No. 17 (Prepared by the Oregon Health & Science University Evidence-based Practice Center under Contract No. 290-97-0018.) Rockville, MD: Agency for Healthcare Research and Quality, 2002. Available at: http://www.ahrq.gov/clinic/serfiles.htm
25. Department of Health, Taiwan. Taiwanese Depression Score. Available at: http://www.jtf.org.tw/suicide_prevention/index.htm [In Chinese]
26. Bureau of National Health Insurance. Official website of the Bureau of National Health Insurance. Available at: http://www.nhi.gov.tw/
27. Risk Assessment Tool for Estimating 10-year Risk of Developing Hard CHD. Available at: http://hin.nhlbi.nih.gov/atpiii/ calculator.asp?usertype=prof
28. Cadarette SM, Jaglal SB, Kreiger N, et al. Development and validation of the Osteoporosis Risk Assessment Instrument to facilitate selection of women for bone densitometry. CMAJ 2000;162:1289-94.
29. Department of Health, Taiwan. Two-step Breast Cancer Screening. Available at: http://health99.doh.gov.tw/p_health/detail.asp?no=25 [In Chinese]
30. Taiwan Medical Association for the Study of Obesity. Official Website of the Taiwan Medical Association for the Study of Obesity. Available at: http://www.obesity.org.tw
31. US Preventive Services Task Force. Effect of Aspirin on Risk for Coronary Heart Disease in Primary Prevention Trials. Available at: http://www.ahrq.gov/clinic/3rduspstf/aspirin/sumtab2.htm
32. Nordone DS, Westerberg D, Wolf D. Does screening for diabetes in at-risk patients improve long-term outcomes? J Fam Prac 2004;53:401-19.
33. Rembold CM. Number needed to screen: development of a statistic for disease screening. BMJ 1998;317:307-12.
34. Morre RA, Gavaghan DJ, Edwards JE, et al. Polling data for number needed to treat: no problems for apples. BMC Med Res Methodol 2002;epub2:2.
35. Simon GE, Manning WG, Katzelnick DJ, et al. Cost-effectiveness of systematic depression treatment for high utilizers of general medical care. Arch Gen Psychiatry 2001; 58:181-7.
36. US Preventive Services Task Force. Randomized Controlled Trials o f Mammography Among Women Aged 39-74. Available at: http://www.ahrq.gov/ clinic/3rduspstf/breastcancer/bcsumtab4.htm
37. Gate TJ. Screening for cancer: evaluating the evidence. Am Fam Physician 2001;63:513-22.
38. Boomsma LJ, van Lidth De Jeude CP. Number needed to screen: a tool for assessment of prevention programs. Ned Tijdschr Geneeskd 2000;49:2345-8.
39. US Preventive Services Task Force. Screening for Osteoporosis in 10,000 Postmenopausal Women, Hip and Vertebral Fracture Outcomes by 5-year Age Intervals. Available at: http://www.ahrq.gov/clinic/3rduspstf/ osteoporosis/osteotab5.htm
40. Ess SM, Szucs TD. Medical-economical aspects of high sensitivity C-reactive protein assay for the prediction of coronary heart disease. An analysis in Germany and Italy. Ital Heart J 2001;2:181-8.
41. US Preventive Services Task Force. Incremental Cost-effectiveness Ratios for Diabetes Screening. Available at: http://www.ahcpr.gov/clinic/ 3rduspstf/diabscr/dbcost-tab4.htm
42. Garber AM, Browner WS, Hulley SB. Cholesterol screening in asymptomatic adults, revisited. Ann Intern Med 1996; 124:518-31.
43. Goldman L, Weinstein MC, Goldman P, et al. Cost-effectiveness of HMG-CoA reductase inhibition for primary and secondary prevention of coronary heart disease. J Am Med 1991;265:1145-51.
44. Weinstein MC, Stason WB. Hypertension: A Policy Perspective. Cambridge, MA: Harvard University Press, 1976.
45. Littenberg B. A practice guideline revisited; screening for hypertension. Arch Intern Med 1995;122:937-9.
46. Brunner E, Cohen D, Toon L, Cost effectiveness cardiovascular disease prevention strategies: a perspective on EU food based dietary guidelines. Public Health Nutr 2001;4: 711-5.
47. Valenstein M, Vijan S, Zeber JE, et al. The cost-utility of screening for depression in primary care. Ann Intern Med 2001;134:345-60.
48. US Preventive Services Task Force. Calculated Incremental Cost-effectiveness Ratios from Five Major Cost-effectiveness Analysis. Available at: http://ahrq.gov/clinic/3rduspstf/colorectal/appxc.htm
49. Salzmann P, Kerlikowske K, Phillips K. Cost-effectiveness of extending screening mammography guidelines to include women 40 to 49 years of age. Ann Intern Med 1997; 127:955-65.
50. Salzmann P, Kerlikowske K, Phillips K. Erratum in: Ann Intern Med 1998;128:878.
51. Mandelblatt J, Freeman H, Winczewski D, et al. The costs and effects of cervical and breast cancer screening in a public hospital emergency room. The Cancer Control Center of Harlem. Am J Public Health 1997;87:1182-9.
52. US Congress, Office of Technology Assessment. Effectiveness and Costs of Osteoporosis Screening and Hormone Replacement Therapy. Volume I: Cost-effectiveness Analysis. 1995;OTA-BPH-160:1-61.
53. Chou P, Tung TH, Li CL, et al. Epidemiology of diabetes mellitus in Taiwan. Taiwan J Public Health 2002;21:83-96.
54. Bureau of Health Promotion, Department of Health, Taiwan. Hypertension. Available at: http://health91.bhp.doh.gov.tw [In Chinese]